Raising Funds for Growth Investments and Debt Repayment through Stock Acquisition Rights with Exercise Price Adjustment Provisions
First written in FY2018-Q2. 17 of 21 entries say "Advanced", first in FY2018-Q3. Latest entry: 2026-08-26.
20 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Specific uses: ① ¥800 million for new capital investments related to data-center products, July 2026 to June 2029; ② ¥600 million for new capital investments related to new light-guide devices, July 2026 to June 2029; ③ ¥632 million in increased working capital resulting from the new capital investments in ① and ② above, October 2026 to June 2029.」
The Company issued the 11th and 12th Series of Stock Acquisition Rights and stated plans to allocate estimated net proceeds of ¥2,032 million to capital investments and increased working capital for data-center products and new light-guide devices. - FY2026-H1AchievedAnnual report
「* All of the 10th Series of Stock Acquisition Rights, which include an exercise price adjustment clause, were exercised in full as of 9 September 2025.」
A total of 58,160 rights, corresponding to 5,816,000 shares, under the 10th Series of Stock Acquisition Rights were exercised, generating ¥962.650 million in funding. The financing described as issued and paid in FY2025 has reached the completion stage. - FY2025AdvancedAnnual report
「At a meeting of the Board of Directors held on 21 May 2025, the Company resolved to issue stock acquisition rights through a third-party allotment, with SMBC Nikko Securities Inc. as the planned allottee, including an exercise price adjustment clause, and to enter into a facility agreement after the notification concerning these stock acquisition rights under the Financial Instruments and Exchange Act became effective. Payment was completed on 6 June 2025.」
The issuance and payment for the 10th Series of Stock Acquisition Rights have been completed, and the Company plans to allocate the estimated net proceeds of ¥965,982,960 to new capital investments and increased working capital for the functional thin-film and glass business. - FY2019AchievedAnnual report
「Cumulative number of shares delivered under bonds with stock acquisition rights and other instruments with a clause for adjustment of the exercise price as of the end of the period (shares) 3,800,000 Cumulative funds raised under bonds with stock acquisition rights and other instruments with a clause for adjustment of the exercise price as of the end of the period (thousand yen) 761,520」
The remaining stock acquisition rights equivalent to 411,400 shares under the ninth series were also exercised, bringing the cumulative total to 3,800,000 shares and cumulative funds raised to ¥761.520 million, completing the exercise of the issued rights. - FY2018AdvancedAnnual report
「During the consolidated fiscal year, partial exercise of the ninth series of stock acquisition rights with a clause for adjustment of the exercise price increased capital stock and capital surplus by ¥349.167 million each, and ¥694.911 million in proceeds from the issuance of shares was recognized.」
Exercise of the ninth series of stock acquisition rights reached 3,388,600 shares for the full fiscal year, raising ¥694.911 million. As of the fiscal year-end, stock acquisition rights equivalent to 411,400 shares remained outstanding. - FY2018-Q3AdvancedAnnual report
「During the cumulative third-quarter consolidated period, the partial exercise of the ninth series of stock acquisition rights with a clause for adjustment of the exercise price increased capital stock and capital surplus by ¥196.769 million each. At the end of the third-quarter consolidated period, capital stock was ¥2,292.076 million and capital surplus was ¥530.671 million.」
Partial exercise of the ninth series of stock acquisition rights took place, increasing capital stock and capital surplus by ¥196.769 million each. The filing also reported the additional issuance by 9 February 2018 of 1,531,200 common shares for total proceeds of ¥304.795 million. - FY2018-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 10 November 2017, the Company resolved to issue the ninth series of stock acquisition rights through a third-party allotment, with a clause for adjustment of the exercise price. The estimated net proceeds from the issuance were ¥1,040,438,000. The Company planned to allocate ¥350,000,000 by March 2019 to investments and loans to JAPAN 3D DEVICES Co., Ltd., an equity-method affiliate (hereinafter, “J3DD”); ¥100,000,000 by March 2020 to loans to Niigata Okamoto Glass Co., Ltd., a consolidated subsidiary; ¥230,000,000 by March 2020 to capital investments in the manufacture of lenses for products using solid-state light sources, a new business, and in the manufacture of functional thin films; ¥160,438,000 toward part of the capital investment in glass frit production; ¥150,000,000 by March 2020 to repay borrowings from financial institutions for working capital; and ¥50,000,000 by March 2020 to fund the increase in working capital associated with higher overseas sales. The funds were to be allocated in accordance with these stated purposes, beginning with those requiring payment earliest.」
The Company resolved to issue the ninth series of stock acquisition rights through a third-party allotment and, for the first time, presented a plan to allocate estimated net proceeds of approximately ¥1.040 billion to investments and loans to J3DD, loans to Niigata Okamoto Glass, capital investments in new businesses and frit production equipment, debt repayment, and working capital associated with higher overseas sales by March 2019 or March 2020.